P904: LOCOMMOTION: A PROSPECTIVE, OBSERVATIONAL, MULTINATIONAL STUDY OF REAL-LIFE CURRENT STANDARDS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA– FINAL ANALYSIS AT 2-YEAR FOLLOW-UP

• Philippe Moreau,
• Katja Weisel,
• Valerio De Stefano,
• Hartmut Goldschmidt,
• Michel Delforge,
• Mohamad Mohty,
• Joanne Lindsey-Hill,
• Dominik Dytfeld,
• Emanuele Angelucci,
• Laure Vincent,
• Aurore Perrot,
• Reuben Benjamin,
• Niels W.C.J. van de Donk,
• Enrique Ocio,
• Ester in ‘t Groen-Damen,
• Tito Roccia,
• Jordan Schecter,
• Imene Haddad,
• Vadim Strulev,
• Lada Mitchell,
• Jozefien Buyze,
• Silva Saarinen,
• Octavio Costa Filho,
• Hermann Einsele,
• Maria-Victoria Mateos

Affiliations

Philippe Moreau

1 University Hospital Hotel-Dieu, Nantes, France

Katja Weisel

2 University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Valerio De Stefano

3 Catholic University, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy

Hartmut Goldschmidt

4 University Hospital Heidelberg, Heidelberg, Germany

Michel Delforge

5 University of Leuven, Leuven, Belgium

Mohamad Mohty

6 Sarbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Joanne Lindsey-Hill

7 Nottinghamshire University Hospitals NHS Trust, Nottingham, UK

Dominik Dytfeld

8 Poznan University of Medical Sciences, Poznań, Poland

Emanuele Angelucci

9 Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy

Laure Vincent

10 Centre Hospitalier Universitaire de Montpellier, Montpellier, France

Aurore Perrot

11 Centre Hospitalier Universitaire de Toulouse, Service d’Hématologie, Toulouse, France

Reuben Benjamin

12 School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK

Niels W.C.J. van de Donk

13 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Enrique Ocio

14 Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria, Santander, Spain

Ester in ‘t Groen-Damen

15 Janssen-Cilag BV, Breda, Netherlands

Tito Roccia

16 Janssen Global Services, Raritan, NJ, USA

Jordan Schecter

17 Janssen Research & Development, Raritan, NJ, USA

Imene Haddad

18 Janssen-Cilag, Moulineaux, France

Vadim Strulev

19 Janssen Pharmaceutica NV, Beerse, Belgium

Lada Mitchell

20 Janssen Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

Jozefien Buyze

19 Janssen Pharmaceutica NV, Beerse, Belgium

Silva Saarinen

21 Janssen-Cilag, Espoo, Finland

Octavio Costa Filho

22 Legend Biotech USA Inc, Somerset, NJ, USA

Hermann Einsele

23 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Wuerzburg, Germany

Maria-Victoria Mateos

24 Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Salamanca, Spain